March 30, 2009
SARcode Announces Results of Phase 1 Trial of SAR 1118 Ophthalmic - Genetic Engineering News
SARcode Announces Results of Phase 1 Trial of SAR 1118 Ophthalmic - Genetic Engineering News
SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy
Filtering Out Bad Cholesterol - HealthScout
ST. LOUIS (Ivanhoe Newswire) — High cholesterol — thats a number of 240 or higher — over 34 million American adults have it. For some, diet and exercise can bring it down, but for others, even medication wont help. Now, patients have another
Octapharma AG Announces First-Ever Research Grants Program - Phramalive.com
LACHEN, Switzerland & HOBOKEN, N.J.–(BUSINESS WIRE)–Mar 30, 2009 - Octapharma AG , one of the world’s largest plasma products manufacturers, is celebrating its 25 th anniversary by demonstrating its commitment to cutting-edge clinical research with
Economy booster: California looking to ban plasma TVs - Hotair.com
California has a rapidly-expanding budget shortfall, unemployment going above 10% for the first time since the early 1980s, and perhaps the worst business climate in the nation, excepting Michigan. How does the state plan to boost the economy